HCV Institute
LifeGuide
Mirror Image
With a new institute for HCV, AAHIVM shows parallels between treating it and HIV
by Larry Buhl
More HIV providers are treating hepatitis C than...
HCV Insurance Restrictions
LifeGuide
Hep Talk
Who Benefits?
Patient advocates decry restitutions on medications
by Larry Buhl
There is agreement in the medical community that a revolution is underway for the treatment...
HCV Care Cascade
LifeGuide
Breaking the Bottlenecks
A new focus on cascade of care seeks to expand screening & treatment
by Larry Buhl
Originally coined to describe the continuum of care—and...
HCV Behind Bars: Part 2
LifeGuide
HCV Behind Bars: Part II
How one state grapples with hepatitis c in the correctional system
by Larry Buhl
In the August issue’s Hep Talk I covered...
HCV Behind Bars: Part 1
LifeGuide
Treatment Behind Bars
Part I: Who pays for direct-acting antiretrovirals in prisons?
by Larry Buhl
The new class of direct-acting antiretrovirals (DAAs) that have revolutionized treatment of...
Hep Advocacy Goes Global
LifeGuide
All Around the World
The war on hepatitis goes global
by Larry Buhl
The hepatitis crisis has been a global one for some time, but 2014 marks...
Hep A Prevention
LifeGuide
Food for Thought
Hepatitis A prevention efforts spark controversy
by Larry Buhl
The hepatitis C virus gets a lot of attention, and rightly so, because it can...
HCV & Underreporting
By the Numbers
While HCV prevalence is down, the rate of morbidity may be going up
by Larry Buhl
New data on the prevalence of hepatitis C...
Race to the Hep C Cure
Race to the Cure
Who are the biggest players now in eradicating hepatitis C?
by Larry Buhl
Beyond the implementation of the Affordable Care Act, one of...
Coffee & HCV
Coffee Talk
Two studies shed light on HCV prevention & treatment
by Larry Buhl
A study on the long-term infectiousness of the hepatitis C virus (HCV) has...
LATEST POSTS
Ron B: Cover Story
“You had me at Angels in America,” I tell Ron B. when I see her at the Manhattan Neighborhood Network studios, in New York...
